help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRIEVA, J. L.
Right arrow Articles by WANNER, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRIEVA, J. L.
Right arrow Articles by WANNER, A.

Am. J. Respir. Crit. Care Med., Volume 161, Number 1, January 2000, 293-296

Effect of an Inhaled Glucocorticosteroid on Airway Mucosal Blood Flow in Mild Asthma

JORGE L. BRIEVA, IGNACIO DANTA, and ADAM WANNER

Division of Pulmonary and Critical Care Medicine, University of Miami School of Medicine, Miami, Florida

We determined airway mucosal blood flow (Qaw) and FEV 1 before and after inhaled albuterol in 19 glucocorticosteroid (GS)-naive patients with mild intermittent asthma, and assessed the effects of a 2-wk course of fluticasone propionate (FP; 440 µg daily) on these parameters. Twelve healthy nonsmokers served as controls. Baseline Qaw was 55.5 ± 0.7 µl/min/ml (mean ± SE) in the asthmatic subjects and 44.2 ± 0.7 µl/min/ml in the controls; the respective FEV1 values were 2.8 ± 0.2 L and 3.4 ± 0.2 L (p < 0.01 for both parameters). Albuterol increased Qaw by 27 ± 3% in the control subjects (p < 0.01) but had no effect on Qaw in the asthmatic subjects; it increased FEV 1 by 7 ± 1% and 6 ± 1% in the two groups, respectively. Qaw decreased to 49.2 ± 0.8 µl/min/ml (p < 0.05 versus baseline), and the Qaw responsiveness to albuterol was restored ( +21 ± 2%; p < 0.05) in the asthmatic subjects after FP. Eleven asthmatic subjects stopped using FP at this time; 2 wk later, their Qaw returned to baseline (55.2 ± 0.9 µl/min/ml) and they lost the Qaw responsiveness to albuterol. Mean ( ± SE) FEV1 and FEV1 responsiveness to albuterol were not affected by FP. The GS-sensitive increase in Qaw and its hyporesponsiveness to albuterol in asthmatic subjects may be consequences of airway inflammation. Brieva JL, Danta I, Wanner A. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma.




This article has been cited by other articles:


Home page
ThoraxHome page
P Paredi and P J Barnes
The airway vasculature: recent advances and clinical implications
Thorax, May 1, 2009; 64(5): 444 - 450.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. D. Noble, J. B. McCafferty, A. P. Greening, and J. A. Innes
Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma
Eur. Respir. J., April 1, 2007; 29(4): 676 - 681.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Paredi, S. Ward, D. Cramer, P. J. Barnes, and S. A. Kharitonov
Normal Bronchial Blood Flow in COPD Is Unaffected by Inhaled Corticosteroids and Correlates With Exhaled Nitric Oxide
Chest, April 1, 2007; 131(4): 1075 - 1081.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Wanner, E. S. Mendes, and N. D. Atkins
A simplified noninvasive method to measure airway blood flow in humans
J Appl Physiol, May 1, 2006; 100(5): 1674 - 1678.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. S. Mendes, M. A. Campos, and A. Wanner
Airway Blood Flow Reactivity in Healthy Smokers and in Ex-Smokers With or Without COPD.
Chest, April 1, 2006; 129(4): 893 - 898.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Horvath and A. Wanner
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Eur. Respir. J., January 1, 2006; 27(1): 172 - 187.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Rhen and J. A. Cidlowski
Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.
N. Engl. J. Med., October 20, 2005; 353(16): 1711 - 1723.
[Full Text] [PDF]


Home page
CMAJHome page
Pharmacotherapy -- treatment of intermittent asthma with ICSs
Can. Med. Assoc. J., September 13, 2005; 173(6_suppl): S33 - S36.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. A. Kharitonov and P. J. Barnes
Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Wanner, G. Horvath, J. L. Brieva, S. D. Kumar, and E. S. Mendes
Nongenomic Actions of Glucocorticosteroids on the Airway Vasculature in Asthma
Proceedings of the ATS, November 1, 2004; 1(3): 235 - 238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. S. Mendes, M. A. Campos, A. Hurtado, and A. Wanner
Effect of Montelukast and Fluticasone Propionate on Airway Mucosal Blood Flow in Asthma
Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1131 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. R. McFadden Jr.
Acute Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Paredi, G. Caramori, D. Cramer, S. Ward, A. Ciaccia, A. Papi, S.A. Kharitonov, and P.J. Barnes
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
Eur. Respir. J., March 1, 2003; 21(3): 439 - 443.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Paredi, S.A. Kharitonov, and P.J. Barnes
Exhaled breath temperature in asthma
Eur. Respir. J., January 1, 2003; 21(1): 195 - 195.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A.A. Acuna, J. Gabrijelcic, E.M. Uribe, R. Rabinovich, J. Roca, J.A. Barbera, K.F. Chung, and R. Rodriguez-Roisin
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
Eur. Respir. J., May 1, 2002; 19(5): 872 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. PAREDI, S. A. KHARITONOV, and P. J. BARNES
Faster Rise of Exhaled Breath Temperature in Asthma . A Novel Marker of Airway Inflammation?
Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 181 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. Horvath, T. Lieb, G. E. Conner, M. Salathe, and A. Wanner
Steroid Sensitivity of Norepinephrine Uptake by Human Bronchial Arterial and Rabbit Aortic Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. J. VANACKER, E. PALMANS, J. C. KIPS, and R. A. PAUWELS
Fluticasone Inhibits But Does Not Reverse Allergen-Induced Structural Airway Changes
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 674 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Brieva and A. Wanner
Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects
J Appl Physiol, February 1, 2001; 90(2): 665 - 669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society
  CCM abstracts